1. Cliff Strader, Program Manager Office of Epidemiology and Health Surveillance, EH-53 May 23, 2006 Status and Outlook for the Illness and Injury Surveillance Program

2. SELECTED IISP ACCOMPLISHMENTS AND CHANGES: 2004-2006 Completed 2002 Site Reports and posted to web site. Format change for 2003 reports planned. Submitted Health of the DOE Workforce presentation for senior management (prepared by Dr. Richter) Draft rollup report completed, short version under development Proposed nanotechnology surveillance Program trifold brochure updated Initiated work on Technical Standard for Illness & Injury Surveillance (Jasmine Kenney) Initial analysis of pilot industrial hygiene data (Paul Wambach) Outbreak investigations at DOE-HQ and INL (RESL) Fernald left the program HQ pandemic flu planning

3. 10 CFR PART 851: WORKER SAFETY AND HEALTH PROGRAM, FINAL RULE 6922 Federal Register / Vol. 71, No. 27 / Thursday, February 9, 2006 / Rules and Regulations “DOE further notes that worker safety and health committees and worker representatives can obtain trend data on illness and injury and trend data on safety from the Office of Environment, Safety and Health’s offices of Epidemiology and Health Surveillance, Performance and Assessment, respectively.”

4. RATES OF PSYCHOLOGICAL DIAGNOSES, 1995-2002

5. ANXIETY AND NEUROSES

6. ALL PSYCHOLOGICAL DIAGNOSES: RATES BY SITE AND GENDER, 1995-2002

7. INITIAL INL AUTOIMMUNE DISEASE REPORT Report received August 2004 Employee with neurologic symptoms but no specific diagnosis to date. Employee knew others at worksite with possibly similar conditions Several former RESL employees might have related diseases. Diseases included neurologic symptoms, multiple sclerosis, fibromyalgia, arthritis Could an occupational exposure be involved?

8. HEADQUARTERS CONCERNS Diseases not similar enough to define disease cluster, Lack of clinical diagnoses, Cases diagnosed over a period of approximately six years, No specific occupational exposure suspected, and NIOSH review concluded insufficient evidence of cluster to warrant investigation

9. RATE OF AUTOIMMUNE DISEASES BY AGE GROUP AVERAGED OVER 8 YEARS, INEL VS. OTHER SITES

10. AUTOIMMUNE DISEASE AT INL VS. OTHER SITES, 1995-2002

11. WHERE TO FROM HERE? Site recruitment Technical Standard Dosimetry module Industrial Hygiene module Nanotechnology surveillance Special reports, roll-up reports, annual reports Pilot wellness projects HQ Pandemic Disease Surveillance